PIK3CA c.292_293delinsGA ;(p.F98D)

Variant ID: 3-178916905-TT-GA

NM_006218.2(PIK3CA):c.292_293delinsGA;(p.F98D)

This variant was identified in 3 publications

View GRCh38 version.




Publications:


Inhibition of RPS6K reveals context-dependent Akt activity in luminal breast cancer cells.

Plos Computational Biology
Erdem, Cemal C; Lee, Adrian V AV; Taylor, D Lansing DL; Lezon, Timothy R TR
Publication Date: 2021-06

Variant appearance in text: PI3K: F98D
PubMed Link: 34191793
Variant Present in the following documents:
  • Main text
View BVdb publication page



Successive Statistical and Structure-Based Modeling to Identify Chemically Novel Kinase Inhibitors.

Journal Of Chemical Information And Modeling
Burggraaff, Lindsey L; Lenselink, Eelke B EB; Jespers, Willem W; van Engelen, Jesper J; Bongers, Brandon J BJ; González, Marina Gorostiola MG; Liu, Rongfang R; Hoos, Holger H HH; van Vlijmen, Herman W T HWT; IJzerman, Adriaan P AP; van Westen, Gerard J P GJP
Publication Date: 2020-09-28

Variant appearance in text: PIK3CA: F98D
PubMed Link: 32343143
Variant Present in the following documents:
  • Main text
View BVdb publication page



MicroRNA-181a/b-1 over-expression enhances osteogenesis by modulating PTEN/PI3K/AKT signaling and mitochondrial metabolism.

Bone
Zheng, Hongjun H; Liu, Jin J; Tycksen, Eric E; Nunley, Ryan R; McAlinden, Audrey A
Publication Date: 2019-06

Variant appearance in text: PI3K: F98D
PubMed Link: 30898695
Variant Present in the following documents:
  • Main text
View BVdb publication page